Suma Krishnan Krystal Biotech, Inc. (KRYS) insider trading activity
Suma Krishnan is President, R&D of Krystal Biotech, Inc.. Currently has a direct ownership of 1.46 Million shares of KRYS, which is worth approximately $274 Million. The most recent transaction as insider was on Feb 26, 2021, when has been sold 28,400 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.46M
0.82%
3M change
5.62%
12M change
Total Value Held
$274 Million
SK
Suma Krishnan
President, R&D
Pittsburgh, PA